v3.24.1.u1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 2,815 $ 774
General and administrative 1,928 480
Total operating expenses 4,743 1,254
Loss from operations (4,743) (1,254)
Other income (expense):    
Interest income 140 0
Interest expense 0 (83)
Other income 0 1
Net loss $ (4,603) $ (1,336)
Loss per share, basic (in dollars per share) $ (0.34) $ (0.39)
Loss per share, diluted (in dollars per share) $ (0.34) $ (0.39)
Weighted average number of shares of common stock, basic (in shares) 13,709,487 3,410,103
Weighted average number of shares of common stock, diluted (in shares) 13,709,487 3,410,103

Source